(Q51932203)
Statements
An adaptive phase I design for identifying a biologically optimal dose for dual agent drug combinations. (English)
1 reference
Sumithra J Mandrekar
1 reference
Yue Cui
1 reference
1 May 2007
1 reference
26
1 reference
11
1 reference
2317-2330
1 reference